J | June 2026 - Browse Articles

26 pages, 903 KB

Open AccessReview

The Impact of Precision Livestock Farming Technologies on Productivity, Animal Welfare, and Environmental Sustainability

by Fernando Mata

J 2026, 9(2), 13; https://doi.org/10.3390/j9020013 - 5 May 2026

Viewed by 686

Abstract

Precision Livestock Farming (PLF) has emerged as an approach in modern animal production, integrating advanced technologies such as sensors, automation, data analytics, and artificial intelligence to enable continuous, individualised monitoring of livestock and their environment. This review examines the impact of PLF technologies on three critical dimensions of livestock systems: productivity, animal welfare, and environmental sustainability. PLF applications, including wearable and environmental sensors, automated feeding and milking systems, and video-based monitoring, allow for early detection of health and behavioural deviations, optimisation of feed efficiency, and improved reproductive and disease management. These technologies support proactive, data-driven decision-making that enhances productivity while promoting animal welfare and reducing the environmental footprint of livestock production. Despite these benefits, the adoption of PLF faces significant challenges, including high initial investment costs, technical limitations, system integration issues, data ownership and privacy concerns, and ethical considerations related to automation. Future research and policy efforts should focus on developing cost-effective, scalable solutions, standardised data frameworks, and supportive regulatory measures to enable equitable and responsible implementation across diverse production systems. By addressing these challenges, PLF offers a pathway towards more efficient, welfare-oriented, and environmentally sustainable livestock production, contributing to global food security and resilient agricultural systems. Full article

► Show Figures

Figure 1

13 pages, 2375 KB

Open AccessOpinion

CsPbI₃ Perovskites at the Edge of Commercialization: Persistent Barriers, Multidisciplinary Solutions, and the Emerging Role of AI

by Carlo Spampinato

J 2026, 9(2), 12; https://doi.org/10.3390/j9020012 - 13 Apr 2026

Cited by 2 | Viewed by 524

Abstract

All-inorganic cesium lead iodide (CsPbI₃) has been investigated for more than a decade as an absorber for perovskite photovoltaics thanks to its attractive bandgap, thermal robustness compared with hybrid perovskites, and compatibility with tandem concepts. Yet, despite remarkable efficiency progress, CsPbI₃ remains far from widespread commercialization. The core roadblock is the metastability of the photoactive black perovskite phases (α/γ/β) against transformation to the photoinactive yellow δ-phase under realistic conditions, amplified by defect chemistry, ion migration, and interfacial reactions. Additional barriers arise from scale-up constraints (film uniformity, throughput, solvent management), long-term operational stability (humidity, heat, UV, bias), and environmental/safety requirements, especially lead containment, sequestration, and end-of-life strategies. This review critically analyzes the intertwined physical, chemical, and engineering factors that still limit CsPbI₃ deployment, with emphasis on how solutions in one domain can fail without co-design in others. This review summarizes state-of-the-art stabilization strategies (size/strain engineering, additive/doping routes, surface/interface passivation, and encapsulation), highlight scalable manufacturing pathways including solvent-minimized and vacuum-assisted approaches, and discuss lead-mitigation technologies such as Pb-adsorbing functional layers. Finally, I argue that artificial intelligence (AI)—from machine-learning stability models to process monitoring, robotic optimization, and digital twins—has become essential to navigate the enormous parameter space of CsPbI₃ materials and manufacturing. It concludes with actionable recommendations and future directions toward bankable, scalable, and sustainable CsPbI₃ photovoltaics. Full article

(This article belongs to the Section Chemistry & Material Sciences)

► Show Figures

Figure 1

14 pages, 1036 KB

Open AccessArticle

Residual Dp71 Expression Is Sufficient to Preserve Retinal Vascular Homeostasis in a Mouse Model of Duchenne Muscular Dystrophy

by Brahim El Mathari, Julia Kuzniar, Ramin Tadayoni, Aurélie Goyenvalle, Alvaro Rendon and Ophélie Vacca

J 2026, 9(2), 11; https://doi.org/10.3390/j9020011 - 1 Apr 2026

Viewed by 551

Abstract

The dystrophin gene encodes multiple dystrophin isoforms with tissue-specific functions, including several shorter isoforms expressed in the central nervous system and retina. While Duchenne muscular dystrophy (DMD) has historically been characterized as a primary myopathy resulting from loss of the full-length dystrophin Dp427, increasing clinical evidence indicates that dysfunction of shorter dystrophin isoforms contributes to significant extramuscular pathology, including retinal disease. In particular, loss of the Dp71 isoform has been implicated in retinal inflammation, blood–retinal barrier breakdown, and pathological angiogenesis. In this study, we investigated whether low-level residual expression of Dp71 is sufficient to mitigate retinal inflammation in the mdx3Cv mouse model, which displays reduced—but not absent—expression of multiple dystrophin isoforms. Western blot analysis revealed that mdx3Cv retinas express approximately 4% of wild-type Dp71 protein levels. Despite this marked reduction, mdx3Cv mice did not exhibit the inflammatory phenotype previously observed in Dp71-null mice. Retinal VEGF protein levels and VEGF receptor (FLT-1 and KDR) mRNA expression were preserved, while VEGF mRNA levels were modestly reduced. Furthermore, expression of inflammatory markers ICAM-1 and ALOX5AP, leukocyte adhesion to retinal vasculature, Aquaporin-4 expression, and BRB permeability to albumin were all comparable to wild-type littermates. Together, these findings demonstrate that minimal residual expression of Dp71 is sufficient to preserve retinal vascular homeostasis and prevent inflammatory and permeability defects in the mdx3Cv retina. These results further suggest that partial dystrophin restoration—at levels achievable with current exon-skipping or gene-based therapies—may be adequate to prevent or attenuate retinal pathology in DMD, providing a realistic and clinically relevant therapeutic target. Full article

(This article belongs to the Section Biology & Life Sciences)

► Show Figures

Figure 1

Journal Menu

Journal Browser

J, Volume 9, Issue 2 (June 2026) – 3 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI